Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

R$81.05
BRL
Last updated on --.
24h volume1.64K
24h highest81.7525 BRL
24h lowest80.2164 BRL
24h Price movement+1.07%

TAK recent prices

24 Hours
+1.07%+R$0.85901
30 days
-3.00%-R$2.476
60 days
-9.32%-R$8.439
90 days
-14.36%-R$13.45

Key data

Previous close80.1911 BRL
Market cap266.31B BRL
Volume1.64K
P/E ratio--
Dividend yield (TTM)--
Dividend amount1.6278 BRL
Next ex-dividend dateSep 30, 2025
Next payment dateDec 11, 2025
EPS diluted (TTM)--
Net income (FY)--
Revenue (FY)--
Last report date--

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Employees (FY)47.46K
Listed onNew York Stock Exchange
Official website

TAK conversion tables

TAKTAK
BRLBRL
0.5 TAK40.52 BRL
1 TAK81.05 BRL
5 TAK405.25 BRL
10 TAK810.5 BRL
BRLBRL
TAKTAK
0.5 BRL0.006169 TAK
1 BRL0.012338 TAK
5 BRL0.06169 TAK
10 BRL0.12338 TAK

FAQ

TAK is trading at R$81.05, +1.07% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TAK stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TAK is currently trading at R$81.05, +1.07% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TAK price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TAK's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TAK; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TAK's historical range and other companies in the sector.
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s market cap is currently 266.31B BRL. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.64K
24h highest81.7525 BRL
24h lowest80.2164 BRL
24h Price movement+1.07%
TAKTAK
BRLBRL
Start trade with TAK Perpetual